Diabetes drug significantly cuts body weight in adults with obesity

A Phase 3 clinical trial published in The New England Journal of Medicine demonstrated an average 14.9% decrease in body weight in adults with obesity or overweight who received an injectable diabetes medication, semaglutide, in addition to lifestyle interventions. Approximately 50% of the participants in the semaglutide group achieved significant […]